Anxiety News and Research

Latest Anxiety News and Research

PIMs usage among elderly patients may increase adverse events and health care costs

A new study provides important evidence that the use of certain potentially inappropriate medications (PIMs) among the elderly may increase adverse events and health care costs.

13 Jan 2010

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

13 Jan 2010

Health Press NA releases new children’s bibliotherapy book on separation anxiety

Health Press NA Inc. (www.healthpress.com) releases a new children’s bibliotherapy book regarding separation anxiety. Bug Bites and Campfires: A Story for Kids About Homesickness addresses anxiety and homesickness in a delightful story about going away to camp.

12 Jan 2010

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

New research has shown that reducing the dosage of dopamine agonist (DA) drugs, a mainstay treatment for Parkinson's disease (PD), sometimes causes acute withdrawal symptoms similar to those reported by cocaine addicts -- including anxiety, panic attacks, depression, sweating, nausea, generalized pain, fatigue, dizziness and drug cravings. These symptoms can be severe, and are not alleviated by other PD medications.

12 Jan 2010

15% of parents still experience post traumatic stress disorder six months after child's injury

According to research by The Children's Hospital of Philadelphia (CHOP) recently published in the Journal of Traumatic Stress, one month after their child was injured 27 percent of parents experienced acute stress disorder or significant traumatic stress symptoms, including re-experiencing the incident, avoiding reminders of the incident, and increased general anxiety or jumpiness.

12 Jan 2010

Yoga lowers number of compounds in blood and reduces inflammation

Regularly practicing yoga exercises may lower a number of compounds in the blood and reduce the level of inflammation that normally rises because of both normal aging and stress, a new study has shown.

12 Jan 2010

Multigene test results impact physicians and patients' decisions on breast cancer therapy

A 21-gene test that predicts whether early stage breast cancer patients will benefit from chemotherapy is having a big impact on treatment decisions by patients and doctors alike.

12 Jan 2010

Interest in studying psychology on the rise

"I hope I will be able to touch the lives of people when they most need help and to offer them advice and guidance."

9 Jan 2010

EON Reality supports BBU with immersive EON Icube environment for virtual reality therapy project

EON Reality, the world's leading interactive 3D software provider, supports the Babes-Bolyai University (BBU), in Cluj-Napoca, Romania with an immersive EON Icube environment for a virtual reality therapy project.

9 Jan 2010

Excessive sweating disorder can negatively influence job prospects

If success is one per cent inspiration and ninety-nine percent perspiration, then it might follow that the Hyperhidrosis sufferer should have no trouble gaining employment. Not so fast.

9 Jan 2010

MUHC unveils new Lung Cancer Navigation Program

A diagnosis of lung cancer can come as a hard blow. The disease has one of the highest mortality rates of all cancers and the sheer complexity of therapy - often involving radiation, chemotherapy and surgery - can leave patients feeling confused and isolated. To help these patients navigate through the complicated treatment process and medical appointments, the MUHC has unveiled its new Lung Cancer Navigation Program (LCNP).

8 Jan 2010

Sciele Pharma announces the U.S. availability of Adrenaclick

Sciele Pharma, Inc., a Shionogi company, today announced the U.S. availability of Adrenaclick™, a single-dose, epinephrine auto-injector for the emergency treatment for severe allergic reactions (Type I) such as anaphylaxis.

8 Jan 2010

Majority of long-term cancer survivors do not have access to personalized care services

An increasing number of people are surviving cancer, but many do not receive the services and support they need in the long term, Macmillan Cancer Support has said.

8 Jan 2010

Study reveals multiple ultrasound scans are more pronounced in low-risk pregnancies

Current use of prenatal ultrasounds in women with singleton pregnancies is 55% greater than in 1996, even in low-risk pregnancies. More than one-third (37%) of pregnant women now receive 3 or more ultrasound tests in the second and third trimesters of a given pregnancy, found an article http://www.cmaj.ca/embargo/cmaj090979.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

6 Jan 2010

Findings suggest abuse is a risk factor for chronic headache

Researchers from the American Headache Society's Women's Issues Section Research Consortium found that incidence of childhood maltreatment, especially emotional abuse and neglect, are prevalent in migraine patients.

5 Jan 2010

VELCADE sNDA receives FDA approval

Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE, which expands the label to include long-term (median follow-up 36.7 months) overall survival (OS) data from the landmark VISTA trial and provides specific dosing recommendations for patients with hepatic impairment. The VISTA trial examined the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).

5 Jan 2010

Talampanel slows progression of amyotrophic lateral sclerosis

A drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening that comes with amyotrophic lateral sclerosis (ALS), scientists report after completing a Phase II clinical trial-an early, small-scale test to show if the drug works and continues to be safe.

5 Jan 2010

Impending job cuts raises anxiety at Peterborough Regional Health Centre

The Central East LHIN, which oversaw a peer review that resulted in 220 job cuts in the Rouge Valley Healthcare system is deliberately downplaying the potential impact of the same process in Peterborough, says the union representing 540 employees at the Peterborough Regional Health Centre.

4 Jan 2010

WDI utilizes DXA analysis for fitness and weight management programs

Women's Digital Imaging of Ridgewood (WDI), has begun using Dual Energy X-ray Absorptiometry (DXA), a technology developed to screen for osteoporosis (bone loss), to measure body fat in patients who want a more accurate method of establishing goals and measuring results for weight management and fitness programs.

4 Jan 2010

Sharing Miracles: A TV program that features inspirational stories of real patients

Major League Baseball slugger Aaron Boone will be featured on January's episode of Sharing Miracles - a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients. Sharing Miracles airs every week on more than 300 television stations nationwide.

31 Dec 2009

Anxiety News and Research

Latest Anxiety News and Research

PIMs usage among elderly patients may increase adverse events and health care costs

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

Health Press NA releases new children’s bibliotherapy book on separation anxiety

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

15% of parents still experience post traumatic stress disorder six months after child's injury

Yoga lowers number of compounds in blood and reduces inflammation

Multigene test results impact physicians and patients' decisions on breast cancer therapy

Interest in studying psychology on the rise

EON Reality supports BBU with immersive EON Icube environment for virtual reality therapy project

Excessive sweating disorder can negatively influence job prospects

MUHC unveils new Lung Cancer Navigation Program

Sciele Pharma announces the U.S. availability of Adrenaclick

Majority of long-term cancer survivors do not have access to personalized care services

Study reveals multiple ultrasound scans are more pronounced in low-risk pregnancies

Findings suggest abuse is a risk factor for chronic headache

VELCADE sNDA receives FDA approval

Talampanel slows progression of amyotrophic lateral sclerosis

Impending job cuts raises anxiety at Peterborough Regional Health Centre

WDI utilizes DXA analysis for fitness and weight management programs

Sharing Miracles: A TV program that features inspirational stories of real patients

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Anxiety News and Research

Latest Anxiety News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in